首页 正文

Preclinical development of anti-BCMA immunotoxins targeting multiple myeloma

{{output}}
Background: Multiple myeloma (MM) is a B-cell malignancy that is incurable for the majority of patients. New treatments are urgently needed. Recombinant immunotoxins (RITs) are chimeric proteins that are composed of the Fv or Fab... ...